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Steelman SM, Johnson P, Jackson A, Schulze J, Chowdhary BP. Serum metabolomics identifies citrulline as a predictor of adverse outcomes in an equine model of gut-derived sepsis. Physiol Genomics 46: 339 -347, 2014. First published March 11, 2014 ; doi:10.1152/physiolgenomics.00180.2013.-Acute laminitis is an inflammatory disease of the equine foot that often occurs secondarily to sepsis or systemic inflammation associated with gastrointestinal disease. It has been suggested that laminitis is similar to multiple organ dysfunction syndrome in humans, although in horses the weight-bearing laminar epithelium of the foot appears to be the tissue most sensitive to insult and the first "organ" to fail. Metabolomics performed on serum samples collected before (Con) and after (Lmn) experimental induction of gastrointestinal-associated sepsis in six horses detected 1,177 metabolites of both mammalian and bacterial origin in equine serum. Network and correlation analyses suggested a dysregulation of fatty acid metabolism in the Lmn group, as well as an accumulation of organic acids such as lactate. Furthermore, concentrations of the amino acid citrulline were decreased in Lmn samples from all study animals, suggesting that citrulline might be useful as a biomarker to identify critically ill animals that are at risk of developing laminitis. We therefore established normal ranges of plasma citrulline concentrations in a separate group of horses (n ϭ 36) and tested the ability of citrulline to predict adverse outcomes (laminitis or death) in critically ill horses (n ϭ 23). Plasma citrulline was significantly lower in critically ill horses that went on to experience adverse outcomes (n ϭ 6). Further study is required to accurately determine a diagnostic cutoff, but the present data are suggestive of the predictive value of citrulline as a biomarker for laminar failure in equine sepsis. metabolomics; laminitis; MODS ACUTE EQUINE LAMINITIS OFTEN occurs secondary to sepsis and/or systemic inflammatory response syndrome (SIRS) (2, 3, 23) . This disease is characterized by inflammation of the laminar tissue of the foot, which is anatomically analogous to the human nail bed and serves as the mechanical attachment between the hoof capsule and the underlying third phalanx, thus bearing a large portion of the horse's weight. Inflammation of the laminar interface degrades the mechanical attachment and leads to distal rotation and/or displacement of the third phalanx such that the horse's weight rests on the tip of this bone, rather than being distributed over the distal surface of the hoof wall. This causes severe pain, unwillingness to walk, and eventual recumbency. If the pain cannot be alleviated pharmacologically, the horse may be euthanized.
Laminitis shares a number of similarities with human multiorgan dysfunction syndrome (MODS) (2, 3) , including changes in cardiovascular function (11) , leukocyte accumulation in the lungs and liver (9, 32) , and endothelial cell activation (19) . In horses, however, laminar inflammation and mechanical failure generally precede the failure of major organs. As in MODS, several hypotheses suggest that bacterial or endogenous "trigger factors" are released from the injured gastrointestinal tract, enter the bloodstream, and are delivered to the peripheral tissues during the developmental stage (2, 7) . This stage of laminitis represents an animal that is critically ill but has not yet manifested symptoms of laminar tissue failure (i.e., pain and lameness). Importantly, any potential treatment for laminitis must begin during the developmental stage, prior to the onset of foot pain, to be effective (36) . It is thus of critical importance to identify sick animals that are at an immediate risk of developing laminitis and to distinguish this population from animals that will likely recover spontaneously. As part of a comprehensive systems biology approach aimed at identifying candidate trigger factors and potential biomarkers, we performed mass spectrometry-based metabolomic profiling of serum from horses before (Con) and during the developmental stage (Lmn) of carbohydrate-induced laminitis. Our results suggest that concentrations of the nonessential amino acid citrulline were lower in Lmn samples, a finding that was then corroborated in clinical cases of laminitis.
METHODS
Carbohydrate-overload laminitis. Archived serum samples from experimentally induced carbohydrate-overload laminitis (11) were used in the current study. Details of the animal procedures, which were approved by the Animal Care and Use Committee at the University of Missouri, have been published previously (15) . In brief, a wood starch gruel was administered via nasogastric tube (17.5 g/kg body wt) to six female Standardbred horses between the ages of 2 and 3 yr. Serum samples were collected into sterile, evacuated glass tubes prior to starch administration (Con) as well as every 6 h afterward. Laminitis (Lmn) samples used in the current study were taken from the last blood collection prior to the time at which the animal showed the first signs of foot pain (22) .
Clinical cases. To verify results obtained from horses with experimentally induced laminitis, concentrations of selected metabolites (citrulline, D-lactate, and amino acids) were measured in a larger population of animals. IgA, a marker of intestinal immune function, was also quantified. Heparinized plasma was collected from the jugular vein of healthy horses admitted to one of four local (central Texas) veterinary clinics for routine vaccinations, health certificates, or physical examinations (n ϭ 23, Norm). Archived plasma samples from healthy, university-owned horses were also included in this group. To test the hypothesis that plasma citrulline concentrations are reflective of an animal's risk of developing laminitis and not merely reflective of gastrointestinal disease in general, blood samples were collected from a clinical population of horses at risk of developing laminitis secondarily to sepsis or gastrointestinal disease (n ϭ 19, 2-32 yr old). Samples were collected prospectively from animals presenting to one of two local (central Texas) veterinary clinics with symptoms consistent with sepsis or gastrointestinal disease during a 6 mo period from July through December, 2012. Medical treatment of each horse was determined solely by the attending veterinarian and was not altered by inclusion in the study. The ultimate outcome of each case was recorded and used to classify animals into two groups: horses that recovered from their illness (Sick) and those that experienced adverse outcomes [laminitis or death (Adv)]. Laminitis was defined as the development of bilateral foot pain and stilted gait following illness; radiographs confirming rotation of the distal phalanx were performed in some, but not all, cases. A summary table of patient characteristics is presented in RESULTS (Table 4) . Written consent for inclusion in the study was obtained from the owner or owner's agent for all nonuniversity-owned animals. All animal procedures were approved by the Animal Care and Use Committee of Texas A&M University and the Clinical Research Review Committee of the Texas A&M University College of Veterinary Medicine.
Metabolomics. Serum metabolomics analysis was performed by the Metabolomics Core Facility at the University of California, Davis. Samples were extracted with acetonitrile and derivatized with methoxyamine hydrochloride prior to chromatography. Hydrophobic interaction liquid chromatography/quadrupole time-of-flight mass spectrometry (LC/MS) was carried out on a Agilent 1290 Infinity UHPLC coupled with an Agilent 6530 Accurate Mass Q-TOF LC/MS as described previously (10) . Gas chromatography/time-of-flight mass spectrometry (GC/MS) was carried out on a LECO Pegasus III GC-TOF mass spectrometer with a Gerstel MPS II injector (10) .
Amino acid analysis. Amino acid concentrations of equine serum and plasma were analyzed by the Texas A&M University Protein Chemistry Laboratory according to published methods (35) . Samples were filtered (Amicon 5K MWCO Spin Filters; Millipore, Billerica, MA) to remove debris and intact proteins were then precipitated by a methanol-chloroform protocol. Each sample was assayed in duplicate using a Hewlett Packard Amino Quant II system.
Other assays. Serum and plasma IgA were measured by ELISA as described previously (31) using a matched pair of anti-equine IgA antibodies (Bethyl Labs, Montgomery, TX). Serum and plasma concentrations of D-lactate were determined by colorimetric assay (Abcam, Cambridge, UK) according to the manufacturer's instructions.
PCR. Equine tissue samples from the stomach, small intestine, cecum, and large intestine were collected at necropsy from horses euthanized for nongastrointestinally related reasons (postmortem interval Ͻ 2 h). RNA was extracted from each of the tissue samples with QIAzol cell lysis buffer (Qiagen, Valencia, CA) followed by RNA cleanup (RNeasy RNA Isolation Kit, Qiagen) and then reverse transcribed to cDNA (Superscript VILO; Invitrogen, Carlsbad, CA). PCR primers were designed for each of the enzymes carbamoylphosphate synthetase I (CPS1), N-acetylglutamate synthase (NAGS), and ornithine transcarbamoylase (OTC), which collaboratively produce citrulline in the mitochondria of enterocytes (27) , based on predicted equine cDNA sequences deposited in the National Center for Biotechnology Information database. Primer sequences are listed in Table 1 . cDNA was PCR-amplified from each tissue type, and PCR products were separated by agarose gel electrophoresis.
Data analysis. Multivariate principal component analysis (PCA) of metabolomics data were performed using MetaboAnalyst [http:// www.metaboanalyst.ca; (38) ]. Data were mean-centered and divided by the standard deviation of each variable using the autoscaling function prior to PCA and partial least-squares discriminant analyses. Two-tailed, paired t-tests were used to identify differentially abundant metabolites in Con and Lmn samples and ANOVAs were used to evaluate differences between Norm, Sick, and Adv groups. Tukey's method was used for post hoc testing. Correlation analyses were performed in R using the "cor" function. Relationships with a Pearson's correlation coefficient Ͼ 0.9 were considered "strong" (6) and were used to build correlation networks. Correlation and biochemical relationship networks were created in Cytoscape (28) . Biochemical relationships were based on a previously published network [MetaMapp, (1)], and nodes and edges for an additional 40 metabolites were added to the MetaMapp network using the Kyoto Encyclopedia of Genes and Genomes (KEGG) reaction pairs database as described by Barupal et al. (1) . Correlation networks were assembled de novo based on the results of the correlation analysis. Predictive values of potential biomarkers were assessed using receiveroperator curves and standard calculations of specificity and sensitivity. All univariate analyses were performed in Prism 2.0 (GraphPad, La Jolla, CA). A P value Ͻ 0.05 was considered sufficient to reject the null hypothesis for all data sets except during the initial screening for differentially abundant metabolites, where a P value of 0.1 was used.
RESULTS
Serum metabolites in healthy horses. Using a combination of GC/MS and LC/MS, we detected 1,177 metabolites in equine serum (Con samples, n ϭ 6; Data Supplement). 1 Of these, 155 metabolites were identified as named compounds: 124 are also listed in the National Library of Medicine's PubChem database, and 107 are listed in the KEGG. An additional 125 compounds were annotated with mass spectra, quantifier ions, and retention indexes, although their identities remain unknown. These are described by their BinBase number (http:// fiehnlab.ucdavis.edu/projects/binbase_setupx) in the Data Supplement. The remaining 897 unnamed compounds were detected by LC/MS and were only identified by their m/z ratio and retention time; no further information regarding their origin or function is currently known, although efforts to identify these compounds are ongoing.
Serum metabolome during sepsis. No additional metabolites were discovered after the induction of sepsis. As the metabolomics portion of the study was designed as an initial screening and hypothesis-generating experiment, a relatively lax statistical threshold was chosen to identify potential differences between groups. The concentrations of 160 compounds differed (P Ͻ 0.1) between Con and Lmn samples. Of the 160 differentially expressed metabolites, 17 could be definitively identified as named compounds and an additional 11 were annotated by a BinBase number. The remainder of the differentially abundant metabolites (143) were described only by mass and retention time; differentially abundant compounds that could be unambiguously identified are listed in Table 2 . Novel compounds not previously associated with sepsis included 3-phenyllactic acid, salicylic acid, and hippuric acid. Salicylic acid, the active form of acetylsalicylic acid, was upregulated about threefold, although none of the horses were administered medications or feed containing acetylsalicylic acid during the study. Interestingly, the immunomodulatory lipid palmitoyl lysolecithin was decreased during sepsis, as was the gut-derived amino acid citrulline.
Classification of Con and Lmn groups. Supervised and unsupervised multivariate statistics were used to describe global differences between Con and Lmn groups. Results from LC/MS and GC/MS were analyzed separately to evaluate the relative utility of each method in discrimination between groups. PCA of GC/MS data showed a large overlap between Con and Lmn samples (Fig. 1A) . The LC/MS data set, on the other hand, showed complete separation of Con and Lmn samples (Fig. 1B) .
Network analyses. A biochemical relationship network was constructed using both structural similarity and known biochemical reactions among 293 metabolites ( Fig. 2A) . Compounds detected in the present study were distributed throughout the network, although differentially abundant metabolites tended to cluster together. Closer examination of this cluster (Fig. 2B) revealed that most of these metabolites are related by structural similarity (dashed gray lines) rather than shared biochemical reactions (solid blue lines). Network analysis of 1 The online version of this article contains supplemental material. correlations between metabolite concentrations was performed for Con and Lmn groups separately and shows that each group has a similar number of nodes and edges (Con, 137 nodes and 377 edges; Lmn, 131 nodes and 381 edges), although the distribution of these differs between groups (Fig. 3, A and B) . A comparison of the most highly connected nodes in each network (Table 3 ) reveals the acylcarnitines as central players in the Lmn network but not the Con network, suggesting that acylcarnitines are in disequilibrium with other metabolites during laminitis. Conversely, the concentrations of saturated fatty acids were found to be highly correlated in the Con network (Fig. 3C) ; these connections were lost in the Lmn group (Fig. 3D) , suggesting a disruption in the flow of substrates through the fatty acid synthesis pathway.
Validation of selected metabolites. Two differentially expressed metabolites were selected for further investigation based on their potential involvement in the pathogenesis of laminitis. We found that D-lactate, a product of many gastrointestinal bacteria, was undetectable in Con samples but was markedly elevated in Lmn samples (P Ͻ 0.05, Fig. 4A ). The second metabolite, citrulline, was selected on the basis of its highly significant P value (0.017), its consistent decrease in all six experimental animals, and its ability to discriminate completely between the Con and Lmn groups (Con range, 3,463-5,222 peak intensity; Lmn range, 2,440 -3,460 peak intensity; Data Supplement). Targeted amino acid analysis by HPLC confirmed results obtained with mass spectrometry, with absolute concentrations of citrulline in LMN samples being ϳ60% of Con samples (P Ͻ 0.05, Fig. 4B) . A reduction in interindividual variation was noted when citrulline concentrations were normalized to total free amino acid concentration (coefficient of variation 25 and 39% for percentages and absolute values, respectively).
As citrulline is primarily associated with dysfunction of the small intestine, we looked for expression of the citrullineproducing enzymes CPS-1, NAGS, and OTC in equine stomach, small intestine, cecum, and large intestine. We found that NAGS and OTC were expressed in several areas of the gastrointestinal tract (12, 27) , but CPS-1 was located exclusively in the small intestine (data not shown).
Predictors of adverse outcome in a clinical population. Several recent studies have proposed the utility of citrulline as a marker for gastrointestinal dysfunction in critically ill human patients (16, 21, 33) . As a first step in testing the suitability of citrulline as a possible biomarker for laminitis, we established normal citrulline concentrations in plasma from 23 healthy horses (Norm, Fig. 5 ). Descriptive statistics of this population are presented in Table 4 . We then measured citrulline in plasma samples from 19 horses admitted to local veterinary clinics for acute gastrointestinal disease and/or sepsis. Horses were then separated into two groups: those that recovered with standard treatment protocols (i.e., intravenous fluids, mineral oil gavage, pharmaceutical pain management), designated the Sick group (n ϭ 13) and those that went on to experience adverse outcomes [laminitis (n ϭ 5) or death (n ϭ 1)] even with treatment (Table 4 ). This second group was designated Adv (n ϭ 6). Citrulline concentrations were lower in the Sick and Adv groups than in the Norm group and tended to be lower in the Adv group than the Sick group (Fig. 5, P ϭ 0.08) . The sensitivity and specificity of citrulline as a marker of Sick horses that will develop laminitis or need to be euthanized were calculated using a cutoff of 2.1%: citrulline had a sensitivity of 83%, a specificity of 62%, and a negative predictive value of 89%.
Interestingly, several other amino acids also differed significantly (P Ͻ 0.05) among the Norm, Sick, and Adv groups (Table 5) . Alanine, valine, and glycine were all elevated in the Sick and/or Adv groups, whereas serine was decreased in both Sick and Adv animals. None of these amino acids were identified as being differentially abundant in the metabolomics experiment (Con vs. Lmn groups, Data Supplement). Only glycine differed significantly between the Sick and Adv groups and was able to predict the onset of laminitis with similar accuracy as citrulline (area under the curve 0.82, P ϭ 0.04, sensitivity 83%, specificity 69%, negative predictive value 89%; Fig. 4B ). Finally, we compared the predictive value of citrulline with that of D-lactate and IgA, which are commonly used in human medicine as indicators of the severity of gut-origin sepsis. Neither D-lactate or IgA differed significantly among the Norm, Sick, and Adv groups (Fig. 6) .
DISCUSSION
In the present study, we used a global, nonbiased metabolomics approach to investigate possible causes and biomarkers of laminitis, a common sequel of equine sepsis and SIRS. Our data suggest an accumulation of organic acids as well as disruption of fatty acid metabolism during sepsis. Some of the metabolites that were differentially abundant during sepsis have been previously described, although many are novel and have the potential to provide insight into the pathogenesis of this disease. These concepts are discussed in detail below.
Serum metabolome during sepsis. The description of the serum metabolome during critical illness has recently become the focus of a number of clinical and preclinical studies (8, 13, 14, 29, 37) . The majority of these studies have sought to identify biomarkers to either to assist with differential diagnoses, such as sepsis versus SIRS or Gram-positive sepsis versus Gram-negative sepsis, or to predict certain outcomes, including end organ failure. Indeed, a recent review discussed 178 different biomarkers for sepsis (24) but highlighted the failure of most of these to be clinically useful. This could be due in part to the failure of rodent models to accurately recapitulate the clinical or molecular features of human sepsis (24, 30) . There is therefore a pressing need for outbred, large animal models with which to screen findings from rodent models prior to their translation to human trials. Under the umbrella of the "One Health" initiative, equine research into genetic diseases, obesity and metabolic syndrome, exercise, and regenerative medicine is already providing insight into parallel conditions in humans. Although experimental studies with horses can be both expensive and cumbersome, the use of naturally occurring cases in clinical trials could be of benefit to both humans and animals. Indeed, the diagnosis and treatment of equine sepsis mirror those of humans in many respects, including the use of common diagnostic terms and criteria as well as a scoring system to objectively judge severity (5) . Treatment strategies in equines, as in human patients, involve identification and control of the source of infection, correction of hypotension with crystalloids, management of blood glucose concentrations, and administration of low-molecular-weight heparin and broad-spectrum antibiotics (17, 20) . Given the similarities in presentation, diagnosis, treatment, and outcomes of human and equine sepsis, it seems that many opportunities exist for the transfer of knowledge between species.
With this in mind, approximately one-third of the metabolites identified as being differentially abundant in our model (Table 1) have previously been associated with sepsis, SIRS, MODS, or intestinal damage in humans or rodents. Specifically, alterations in lactate (4), acylcarnitine C3 (29), alanine (18), kynurenine (40) , and 3-hydroxybutanoic acid (18) have been described in various models of sepsis and SIRS, whereas citrulline and lysolecithin (41) have both been associated with damage to the intestinal epithelium. The similarity of metabolic changes between human and equine sepsis supports the Acylcarnitine C4  10  66  56  Acylcarnitine C5  2  42  40  Mevalonic acid  2  26  24  Indole 3 lactate  6  28  22  Erythritol  4  24  20  Isoleucine  2  22  20  Quinic acid  2  22  20  Beta alanine  6  24  18  Conduritol beta epoxide  4  22 potential use of horses as a large animal, preclinical model of sepsis. It also suggests that the remaining 11 novel metabolites are promising targets for future exploration. Particularly interesting are the bacterial metabolites 3-phenyllactic acid and indole-3-lactate, as there is some evidence that serum metabolites can be used to distinguish between Gram-positive and Gram-negative sepsis (13) . It must be noted that the identified, differentially abundant metabolites all resulted from the GC/MS and targeted LC/MS analyses. The LC/MS protocol, which revealed a large number of unidentified compounds that differed significantly between groups, generated data that was much more efficient at discriminating between the groups in multivariate testing. Although the identities of these compounds cannot be confirmed without further experimentation, some of the masses are consistent with those of immunomodulatory lipids such as bacterial lactones, resolvins, sulfatide, and ceramide. This suggests that targeted investigation of polar and lipid compounds, which are typically detected by LC/MS, might be extremely informative regarding the pathology of sepsis and SIRS. This also supports our findings from the correlation analyses, which pointed to a dysregulation of fatty acid metabolism during sepsis.
Potential usefulness of biomarkers. Veterinary practitioners are not currently able to distinguish critically ill horses during the developmental (asymptomatic) phase of laminitis from those that will not develop laminitis. The ability to discriminate between these two groups would allow earlier commencement of treatment strategies or, alternatively, provide information that could be used in decisions regarding euthanasia in the face of a poor prognosis. We chose to pursue citrulline as a potential biomarker as it has a direct connection to a well-defined feature of carbohydrate-overload laminitis: namely, intestinal epithelial cell death. Equine gastrointestinal disturbances generally occur in the hindgut, whereas citrulline is thought to be produced only by the small intestine. Our PCR results from equine gastrointestinal tissue indicated that the three enzymes necessary for citrulline synthesis are expressed only in the small intestine, suggesting that this section of the gastrointestinal tract might be damaged during carbohydrate-overload laminitis. In multiple human studies, plasma citrulline has been shown to be reflective of the length of functioning small intestine, amount of villous atrophy, gut barrier function, and acute intestinal failure [recently reviewed by Piton et al. (25) ]. However, equine gastrointestinal disease does not always lead to laminitis, so we first sought to determine whether decreased citrulline is indeed a predictive marker for laminitis or merely a nonspecific result of gastrointestinal disturbances. We collected the majority of clinical samples from horses admitted to local veterinary hospitals for "colic," a broad term encompassing symptoms of gastrointestinal pain, gas, and/or diarrhea resulting from a variety of causes. Plasma citrulline was significantly lower in horses with colic than in healthy controls, suggesting that gastrointestinal disturbances alone can influence circulating citrulline levels. However, citrulline was found to have a strong negative predictive value for laminitis: horses with concentrations Ͼ2.1% were unlikely to develop laminitis. Notably, citrulline outperformed both D-lactate and IgA in discriminating between groups. Decreased IgA and elevated D-lactate have been strongly associated with sepsis in humans (34) and horses (39) , respectively. The lack of difference in D-lactate among groups is likely the result of heterogeneity in animal age, feeding status, stress level, and extent of illness, whereas the robust and consistent elevation in D-lactate seen in the carbohydrate-overload laminitis samples was probably due to the tightly controlled experimental conditions. It should be noted that two horses without gastrointestinal disease, but with presumed sepsis (resulting from severe pneumonia in one case and a retained placenta in the other case), were used in the study. Both went on to develop laminitis and were included in the Adv group. Unfortunately, matched cases (i.e., horses experiencing sepsis without gastrointestinal disease) that did not go on to develop laminitis were not available for inclusion in the Sick group. Taken together, our data suggest that plasma citrulline might be informative in determining the likelihood of a horse developing laminitis during gastrointestinal disease and/or sepsis. The utility of citrulline as Values are presented as means Ϯ SD. Norm, clinically normal horses (n ϭ 23); Sick, horses with colic or sepsis (n ϭ 13); Adv, horses with colic or sepsis that experienced adverse outcomes, including laminitis or death (n ϭ 6). Means within a row without a common letter differ, P Ͻ 0.05. Means without a common letter differ (P Ͻ 0.05).
a biomarker for laminitis will need to be assessed in a larger, prospective trial to confirm the findings of this initial study, identify the ideal sample matrix for citrulline measurement (serum or plasma), and to specifically test the relationship between plasma citrulline levels and sepsis. Nevertheless, the results presented herein represent one of the first attempts to use citrulline as a predictor of adverse outcomes rather than simply as a diagnostic tool (26) .
Conclusions
Our identification of citrulline as a possible predictor of adverse outcomes following colic and sepsis is the first potential biomarker of laminitis to be discovered. Further study of this amino acid is needed to confirm its ability to predict the onset of laminitis following critical illness, along with a convenient and practical assay that can be used in the field by veterinarians. The novel compounds discovered to be differentially abundant in this study, in addition to the as-yet unidentified lipids and polar compounds, are also promising areas of future research. Finally, the ability of citrulline to predict, rather than just reflect, adverse outcomes in equine experimental and clinical sepsis cases provides further evidence for its use as a biomarker in humans.
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